XML 69 R52.htm IDEA: XBRL DOCUMENT v3.24.1
Research and License Agreements (Details) - Apollomics, Inc. - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 30, 2021
Mar. 31, 2020
Dec. 31, 2023
Dec. 31, 2022
Research and License Agreements        
Revenue from sale of clinical supplies $ 1.1   $ 0.0 $ 0.0
Up-front payment received   $ 9.0    
Maximum        
Research and License Agreements        
Milestones based on achievement of certain clinical and regulatory events   75.0    
Milestone payment upon achievement of specified net sales thresholds for all licensed products   $ 105.0    
Tiered percentage of annual net sales   15.00%